Article

In vitro activity of cefiderocol against multidrug-resistant Gram-negative bacteria and molecular characterization of carbapenem-resistant isolates in Niger

2026-06-25

Abstract excerpt

<title>Abstract</title> <p> Background The emergence and spread of multidrug-resistant (MDR) Gram-negative bacteria represent a major public health threat worldwide, particularly in low- and middle-income countries where therapeutic options are limited. Cefiderocol is a novel siderophore cephalosporin with a unique mechanism of iron-dependent cellular uptake that enables it to overcome many common resistance me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cd0ded1a-cfe0-55e1-b988-1fa62e9acad7
DOI: 10.21203/rs.3.rs-9998917/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of cefiderocol against multidrug-resistant Gram-negative bacteria and molecular characterization of carbapenem-resistant isolates in NigerDOI 10.21203/rs.3.rs-9998917/v1Read

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsSemantic proximity Read

In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii IsolatesSemantic proximity Read

In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinationsSemantic proximity Read

Cefiderocol: An Overview of Its in-vitro and in-vivo Activity and Underlying Resistant MechanismsSemantic proximity Read

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging DataSemantic proximity Read

Phenotypic And Genotypic Characterization of Extended Spectrum Beta- Lactamase-Producing Clinical Isolates of Escherichia coli and Klebsiella pneumoniae in Two Kenyan Facilities: A National Referral and a Level Five HospitalSemantic proximity Read

Real‑world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram‑negative infections: Results from a retrospective studySemantic proximity Read

In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance ProgramSemantic proximity Read

Cefiderocol in Combating Carbapenem-Resistant Acinetobacter baumannii: Action and ResistanceSemantic proximity Read

Molecular characterization of colistin-resistant Klebsiella pneumoniae in a tertiary care hospital: First report of the mcr-1.32 gene in TunisiaSemantic proximity Read

An Overview of Cefiderocol’s Therapeutic Potential and Underlying Resistance MechanismsSemantic proximity Read

Mechanisms of Cefiderocol Resistance in Carbapenemase-Producing <em>Enterobacteriaceae</em>: Insights from Comparative GenomicsSemantic proximity Read